Social media has discovered fibre. The message is consistent and simple: eat more of it. More vegetables, more legumes, more wholegrains, more fermented foods. Your gut bacteria will thank you, your bowel will thank you, your cardiovascular system will thank you. Everyone needs more fibre. The science supports this. The average UK adult consumes around 18g of fibre per day against a recommended intake of 30g. The gap is real and the consequences of chronic fibre insufficiency — constipation, poor glycaemic control, elevated LDL cholesterol, reduced microbiome diversity, increased colorectal cancer risk — are well-documented.
And then there is the person with SIBO who follows the eat-more-fibre advice and spends the next three days in agony. The person with active dysbiosis who adds a prebiotic supplement and watches their bloating double. The post-antibiotic patient whose gut wall is inflamed and compromised, who takes a high-dose probiotic and creates a new problem in the process of solving an old one.
Fibre is not a universal prescription. It is a category requiring more clinical thought than almost any other nutritional intervention — because the same substance that feeds beneficial bacteria in a healthy gut can be a substrate for pathogenic or opportunistic organisms in a dysbiotic one. The person who needs more fibre and the person who needs less, or different, or sequenced differently, often present with identical surface symptoms. The difference is what the GI-MAP shows underneath.
Not All Fibre Is the Same Thing
Dissolves in water to form a gel. Fermented by gut bacteria. Feeds the microbiome. Slows gastric emptying, blunts blood sugar response, reduces LDL cholesterol by binding bile acids. Generally well-tolerated even in compromised guts at low doses.
Does not dissolve. Adds bulk to stool. Speeds intestinal transit. Reduces constipation mechanically. Less fermentable, so less gas produced. Important for bowel regularity and colorectal health but does less for blood sugar or cholesterol.
Most high-fibre foods contain both types in varying ratios. Most fibre supplements emphasise one or the other. Psyllium husk is predominantly soluble — around 70% — making it one of the most versatile fibre supplements clinically, producing both the microbiome-feeding effect of fermentable fibre and the transit-regulating effect of bulk-forming fibre. It is also one of the best-studied, with consistent evidence for LDL reduction, glycaemic control, and constipation relief. The clinical dose for psyllium ranges from 5–10g per day, taken with substantial water — without adequate hydration it can paradoxically worsen constipation by drawing water into the intestinal lumen without providing enough to form a soft stool.
The distinction between soluble and insoluble matters most in two clinical situations: SIBO, where fermentable fibres provide a substrate for bacterial overgrowth in the small intestine; and inflammatory bowel conditions, where insoluble fibre can mechanically irritate an already-inflamed gut wall. In both cases, the instinct to add more fibre can make things significantly worse before they get better — if indeed they get better at all without addressing the underlying condition first.
The SIBO Problem
Small Intestinal Bacterial Overgrowth is exactly what the name suggests: bacteria present in quantities that belong in the colon have colonised the small intestine, where they ferment carbohydrates — including dietary fibre — before they reach the large intestine. The result is gas production in the wrong location, producing the bloating, belching, abdominal distension, and altered bowel habit that characterises the condition.
The clinical picture of SIBO closely mimics IBS, which is why so many SIBO cases spend years managed as functional bowel disorders without resolution. The standard advice for IBS — eat more fibre, increase fermented foods, take a probiotic — is frequently the worst possible intervention for SIBO. Each of these adds fermentable substrate or live bacteria to a small intestine already overwhelmed with both.
Bloating that is worse after high-fibre meals or prebiotic supplements. Distension that builds through the day regardless of what has been eaten. Belching that follows carbohydrate intake. Alternating constipation and diarrhoea that doesn't follow a consistent food trigger. Symptoms that worsened after a course of antibiotics or a period of illness. Low ferritin and B12 despite adequate dietary intake — both nutrients can be consumed by bacteria in the small intestine before absorption occurs.
None of these symptoms are diagnostic. SIBO requires breath testing or clinical assessment to confirm. But the pattern of symptoms worsening with the interventions that should help is an important clinical signal that something different from simple fibre deficiency is happening.
The low-FODMAP approach addresses the SIBO picture by temporarily reducing fermentable carbohydrates — not because FODMAPs are inherently problematic but because in a gut with bacterial overgrowth, every fermentable carbohydrate becomes a problem. Low-FODMAP is not a permanent diet. It is a short-term reduction to reduce the fermentable load while the underlying overgrowth is addressed. Doing low-FODMAP without addressing the SIBO produces temporary symptom relief that reliably returns when the diet is liberalised.
Digestive Capacity — The Variable Nobody Talks About
The other major clinical variable that universal fibre advice ignores is digestive capacity. Fibre, however well-intentioned, must be processed by a gut that has the enzymatic output, motility, and mucosal integrity to handle it. When digestive capacity is compromised — through low stomach acid, insufficient pancreatic enzyme output, or gut barrier damage — fibre can add a mechanical and fermentative load that the gut is not equipped to manage.
The GI-MAP stool analysis measures pancreatic elastase — a direct marker of exocrine pancreatic function and digestive enzyme output. In my clinical experience, low pancreatic elastase is one of the most consistent findings in clients with bloating, undigested food in stool, and poor tolerance to high-fibre foods. The solution is not less fibre indefinitely — it is digestive support while the underlying insufficiency is addressed, followed by a graduated reintroduction as capacity improves.
This is the clinical sequence that social media never describes because it cannot be reduced to a single recommendation: assess digestive capacity → support where deficient → repair gut barrier → reintroduce fermentable fibre progressively → layer in prebiotic and probiotic support once the environment can utilise it appropriately.
"The same fibre that feeds beneficial bacteria in a healthy gut can be a substrate for pathogenic organisms in a dysbiotic one. Knowing which situation you are in requires testing. Guessing produces exactly the wrong intervention at exactly the wrong moment."
Fermented Foods — The Same Story
The fermented foods narrative runs parallel to the fibre narrative and contains exactly the same clinical nuance. Kefir, kimchi, sauerkraut, kombucha — the evidence for their microbiome benefits in a healthy gut is real and growing. A 2021 Stanford study showed that a high-fermented food diet increased microbiome diversity and reduced inflammatory markers significantly. The headlines were appropriately enthusiastic.
The clinical reality in practice is more complicated. Fermented foods introduce live bacteria at high concentrations and produce histamine as a fermentation byproduct. In a person with histamine intolerance — a common finding in clients with gut dysbiosis, mast cell activation, or diamine oxidase (DAO) insufficiency — fermented foods reliably trigger headache, flushing, nasal congestion, and skin reactions. In a person with candida overgrowth, the yeasts in kombucha and water kefir can exacerbate the problem they are intended to address. In a person with SIBO, the live bacteria are being introduced to an environment already overpopulated with bacteria in the wrong location.
These are not rare edge cases. They are common presentations in the population most likely to be seeking gut health advice.
Fibre Supplements — Navigating the Market
Not all fibre supplements are equivalent and the market is now large enough to be genuinely confusing. A few clinical observations:
Psyllium husk — the most versatile and best-evidenced general-purpose fibre supplement. Start low (2–3g) and increase gradually. Always take with substantial water. Organic psyllium is worth the extra cost given that psyllium is frequently grown with significant pesticide use.
Partially Hydrolysed Guar Gum (PHGG) — one of the few fermentable fibres that is well-tolerated in SIBO, producing gas more slowly and at lower quantities than inulin or FOS. The evidence for PHGG specifically in SIBO management is growing and it represents a useful middle ground for clients who need gut motility support without the fermentative blast of standard prebiotics.
Inulin and FOS — potent prebiotic fibres with strong evidence for Bifidobacteria feeding. Also the most likely to cause symptoms in compromised guts. Save these for clients whose GI-MAP shows confirmed Bifidobacteria deficiency and sufficient digestive capacity to handle the fermentative load.
IgG-based gut support (Prebio IgG / Serum Bovine Immunoglobulins) — a different category entirely. These are not fibre in the traditional sense but immunoglobulin-based gut support products that bind and neutralise bacterial toxins and pathogens, reduce intestinal permeability, and support secretory IgA production. For clients with confirmed gut barrier dysfunction on GI-MAP (low sIgA, elevated zonulin, confirmed pathogens), these represent a clinical intervention that pure fibre supplementation does not provide. bio.me and Metagenics both produce reliable formulations.
The Practical Clinical Sequence
Rather than telling every client to eat more fibre — which is true for most people but clinically problematic for a significant minority — the sequence I use in practice is:
- Assess first. GI-MAP stool analysis to understand the microbiome environment, identify pathogens or overgrowths, assess digestive enzyme output, and evaluate gut barrier integrity. This determines whether fibre support is appropriate, which type, and at what dose.
- Address upstream before adding downstream. If there is active SIBO or significant dysbiosis, addressing those first — before adding prebiotic fibre — prevents feeding the wrong organisms with the right supplements.
- Support digestive capacity. Low pancreatic elastase requires digestive enzyme support alongside any fibre intervention. Trying to increase fibre intake in a gut that cannot adequately digest and process it adds load to a system already struggling.
- Repair gut barrier before inoculating. The onion-layer model: nutrients → digestive capacity → gut repair → microbial rebalancing. Probiotics and prebiotics work best in a gut that has been prepared to receive them.
- Introduce fibre gradually and observe. The symptom response to fibre introduction is one of the most useful clinical signals available. Worsening bloating within 24–48 hours suggests fermentative load the gut cannot handle. No response suggests insufficient dose. Gradual improvement over 4–6 weeks is the target.
The average UK adult consumes around 18g of fibre per day. Hunter-gatherer populations, from whom our gut microbiome evolved, consumed an estimated 100–150g per day — a figure so dramatically different from our current intake that it represents one of the most significant nutritional departures of the modern era.
The consequences are visible in the microbiome diversity data: Western populations consistently show lower microbiome diversity than populations eating traditional, high-fibre diets. Lower diversity is associated with higher rates of obesity, inflammatory conditions, autoimmunity, colorectal cancer, and — increasingly — mental health conditions via the gut-brain axis. The case for substantially increasing dietary fibre intake, population-wide, is genuinely compelling.
The case for doing it without understanding your individual gut picture first is less so. The 18g that most people currently eat represents a genuine clinical deficit. But the route from 18g to 30g — and beyond — looks very different depending on what the GI-MAP shows about the environment you are feeding.
Know your gut before you feed it.
The GI-MAP stool analysis shows exactly what's living in your gut, how well your digestive system is functioning, and whether your gut barrier is intact — before you start any fibre or probiotic protocol.
Resilient Gut System → Take the free gut symptom quiz